Phase 2 ICL Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study
Breast NeoplasmsBreast DiseasesCDK4/6 Inhibitor+3 more
Fujian Cancer Hospital2,000 enrolled2 locationsNCT07581834
Recruiting
Phase 2
CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
HFpEF - Heart Failure With Preserved Ejection FractionFontan CirculationSingle Ventricle Heart Disease
Mayo Clinic27 enrolled1 locationNCT06762964
Recruiting
Phase 2
the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer
Breast CancerNeutropenia (Low White Blood Cell Count)Leucogen+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University94 enrolled1 locationNCT07380646
Recruiting
Phase 1Phase 2
PK/PD of Digoxin in Infants With SVHD
Single VentricleInfant ConditionsInfant, Newborn, Diseases+1 more
Duke University20 enrolled2 locationsNCT06613477
Recruiting
Phase 2
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
Cardiovascular DiseasesHeart DiseasesCardiovascular Abnormalities+8 more
Nationwide Children's Hospital24 enrolled1 locationNCT04467671
Recruiting
Phase 1Phase 2
Fibrosis and the Fontan
Single Ventricle
Children's Hospital of Philadelphia145 enrolled1 locationNCT04901975